Kim M, Kim KE, Kwon JH, et al
10.1158/1055-9965.EPI-08-0781
Consistent with semaglutide, it inhibits central appetite, delays gastric emptying, and promotes hypoglycemia, achieving strong appetite control and stable blood sugar regulation to reduce calorie accumulation at the source

Heres an overview of the most popular GLP-1 medications and their key features: Semaglutide (Brand names: Ozempic, Wegovy, Rybelsus Features: Once-weekly injection (Ozempic, Wegovy) or daily oral tablet (Rybelsus) Approved for type 2 diabetes (Ozempic, Rybelsus) and weight management (Wegovy) Benefits: Significant weight loss Improved glycemic control Cardiovascular benefits Dulaglutide (Brand name: Trulicity) Features: Once-weekly injection Approved for type 2 diabetes Benefits: Improved glycemic control Moderate weight loss Cardiovascular benefits Tirzepatide (Brand name: Mounjaro ) Features: Once-weekly injection Approved for type 2 diabetes, under review for weight management Dual GIP and GLP-1 receptor agonist Benefits: Significant weight loss Improved glycemic control Potential cardiovascular benefits Key differences: Efficacy: Semaglutide and tirzepatide generally show the most significant weight loss and glycemic control improvements

T 03/08/2026 n 09/08/2026 BANANABOAT-38 5% Tr gi t ANUA thng 8/2026 Gim 5% trn Tng tin hng